Drug Industry’s Chief Lobbying Group’s Revenue Surpassed $609 Million in 2021

  • 📰 truthout
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

In 2021, the drug industry’s chief lobbying group surpassed $609 million in revenues and spent more than $205 million on lobbying. Via Sludge

PhRMA represents 33 American and multinational drug companies, including the largest ones like Pfizer, Johnson & Johnson, AbbVie, and Merck. Its chief executive office since 2015, Stephen Ubl, was paid more than $6.1 million in 2021, according to the tax filing.

One of PhRMA’s chief aims in 2021 was to kill a proposal that congressional Democrats had been pushing in recent years to allow Medicare to negotiate with drug companies for lower prices and require drug companies to make the lower negotiated prices available to all buyers, including private insurance companies. That proposal sat in Congress as H.R.3, which is by far thein PhRMA’s 2021 lobbying disclosures.

Another large contribution made by PhRMA in 2021 was a $1.7 million donation to Center Forward, which is a nonprofit tied to the conservative Blue Dog Caucus of Democrats that has

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 69. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

PortCityPisces Sludge

대한민국 최근 뉴스, 대한민국 헤드 라인